Abound Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.08K | Hold |
125
| – | – | ﹤0.01% | 532 |
|
|
2025
Q1 | $4.25K | Hold |
125
| – | – | ﹤0.01% | 572 |
|
|
2024
Q4 | $4.92K | Hold |
125
| – | – | ﹤0.01% | 531 |
|
|
2024
Q3 | $5.87K | Sell |
125
-18
| -13% | -$846 | ﹤0.01% | 516 |
|
|
2024
Q2 | $7.72K | Hold |
143
| – | – | ﹤0.01% | 410 |
|
|
2024
Q1 | $9.75K | Hold |
143
| – | – | ﹤0.01% | 381 |
|
|
2023
Q4 | $8.95K | Buy |
143
+18
| +14% | +$1.13K | ﹤0.01% | 392 |
|
|
2023
Q3 | $5.67K | Hold |
125
| – | – | ﹤0.01% | 437 |
|
|
2023
Q2 | $7.02K | Hold |
125
| – | – | ﹤0.01% | 407 |
|
|
2023
Q1 | $5.65K | Hold |
125
| – | – | ﹤0.01% | 381 |
|
|
2022
Q4 | $5.08K | Hold |
125
| – | – | ﹤0.01% | 352 |
|
|
2022
Q3 | $8.17K | Buy |
+125
| New | +$8.17K | ﹤0.01% | 293 |
|